Straumann Holding AG (OTCMKTS:SAUHY – Get Free Report) has been given an average rating of “Hold” by the seven analysts that are currently covering the firm, MarketBeat reports. Two investment analysts have rated the stock with a sell recommendation, two have assigned a hold recommendation, one has given a buy recommendation and two have given a strong buy recommendation to the company.
SAUHY has been the subject of a number of research analyst reports. UBS Group upgraded Straumann from a “sell” rating to a “neutral” rating in a report on Tuesday, November 4th. Citigroup reaffirmed a “sell” rating on shares of Straumann in a research note on Wednesday, January 14th. The Goldman Sachs Group cut shares of Straumann from a “strong-buy” rating to a “neutral” rating in a research report on Monday, October 13th. Morgan Stanley restated an “underweight” rating on shares of Straumann in a report on Monday, December 15th. Finally, Deutsche Bank Aktiengesellschaft raised shares of Straumann from a “hold” rating to a “buy” rating in a research report on Friday, October 31st.
Read Our Latest Stock Analysis on SAUHY
Straumann Trading Down 0.4%
Straumann Company Profile
Straumann (OTCMKTS:SAUHY) is a Swiss-based dental technology company that develops, manufactures and markets restorative, regenerative and digital solutions for dental professionals. The company’s core offerings center on implant-supported restorations and components, biomaterials used for bone and soft-tissue regeneration, and a range of prosthetic products used by dentists and dental laboratories to restore oral function and aesthetics.
In addition to implant and biomaterial product lines, Straumann provides digital dentistry solutions that support treatment planning and workflows.
See Also
- Five stocks we like better than Straumann
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
- Wall Street Alert: Buy AES
- Bitcoin is down but your income is about to explode
- A month before the crash
- Trump Devises the Death of the IRS ☠️
Receive News & Ratings for Straumann Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Straumann and related companies with MarketBeat.com's FREE daily email newsletter.
